antisense oligonucleotides (Johns Hopkins University)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Nameantisense oligonucleotides (Johns Hopkins University)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionTranscription factor E2F1 modulators

TargetsTranscription factor E2F1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohns Hopkins Technology Ventures Johns Hopkins University

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A